Episode Synopsis "FORECAST Trial: Interview with Dr. Campbell Rogers"

Alastair and Praveen are joined by Dr. Campbell Rogers, CMO and executive VP at HeartFlow, to discuss the recently-published FORECAST trial. What are the economic and clinical outcomes of selective FFRct use in stable chest pain? Tune in and enjoy! 

Listen "FORECAST Trial: Interview with Dr. Campbell Rogers"

More episodes of the podcast Donut of Destiny

• Building a Cardiac CT Program series: James Parker | Sponsored episode
• Systolic Imaging
• HALT: Basic Science to Clinical Practice | Sponsored episode
• Technologist Perspective: Nikki Weber
• Building a Cardiac CT Program series: Praveen Ranganath
• Finances of Cardiac CT: Conversation with Ahmad Slim
• CT and PCI Planning: Conversation with Carlos Collet | Sponsored episode
• National coronary CT use in the UK: Conversation with Jonathan Weir-McCall
• Building a Cardiac CT Program series: Ricardo Cury
• EVAPORATE-FFRCT: Conversation with Mark Rabbat
• Building a Cardiac CT Program series: Jerry Breen and Eric Williamson
• ACC 2023 - Cardiac CT Highlights
• CAC before cCTA: Conversation with Vinit Baliyan
• Building a Cardiac CT Program: Brian Ghoshhajra (Part 2)
• Building a Cardiac CT Program: Brian Ghoshhajra (Part 1)
• Building a Cardiac CT Program series: James Shambrook
• Building a Cardiac CT Program series: Frank Corrigan
• A Journey in Calcium: Conversation with Dr. Matthew Budoff
• Planning revascularization with CT: interview with Daniele Andreini
• CCT in women with Patricia Rodriguez-Lozano
• Fluoride PET Imaging: Conversation with Alastair Moss
• Phenotyping Disease on Cardiac CT: Conversation with Todd Villines
• Conversation with Tim Fairbairn: ADVANCEing into the Future of Cardiac CT
• Women in Cardiac Imaging - Dr. Martha Gulati (part 2)
• Women in Cardiac Imaging - Dr. Martha Gulati (part 1)
• Conversation with Jim Min: Frontiers in CT and coronary atherosclerosis
• Coronary Calcium - Interview with Dr. Khurram Nasir, Part 2
• Coronary Calcium - Interview with Dr. Khurram Nasir, Part 1
• RAPID-CTCA: Coronary CTA in the ED
• New chest pain guidelines
• FORECAST Trial: Interview with Dr. Campbell Rogers
• Aortic Valve Calcium Scoring
• Training in Cardiac CT
• Artificial Intelligence and Cardiac Imaging
• Rectifying claims about cardiac CT
• Plaque Morphology with Jonathon Leipsic, Part 2
• Plaque Morphology with Jonathon Leipsic, Part 1
• V/M and Coronary CTA: Interview with Charley Taylor
• FFRct in the real world: the ADVANCE registry
• CT-FFR
• HALT, TAVR, and anticoagulation: GALILEO-4D CT substudy
• Adverse plaque features and SCOT-HEART - Interview with Dr. Michelle Williams
• TAVR, HALT, and the PARTNER 3 trial
• Donut of Destiny: LAPSCOTHEART
• CARMENTA: How safe is CT in ACS?
• The VERDICT trial: Coronary CTA in NSTEMI
• COVID-19, acute coronary syndrome, and cardiac CT
• COVID and Cardiac CT
• ISCHEMIA trial